Jeroan Allison to Cyclooxygenase 2 Inhibitors
This is a "connection" page, showing publications Jeroan Allison has written about Cyclooxygenase 2 Inhibitors.
Connection Strength
0.082
-
Chaiamnuay S, Allison JJ, Curtis JR. Risks versus benefits of cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs. Am J Health Syst Pharm. 2006 Oct 01; 63(19):1837-51.
Score: 0.069
-
Patino FG, Allison J, Olivieri J, Mudano A, Juarez L, Person S, Mikuls TR, Moreland L, Kovac SH, Saag KG. The effects of physician specialty and patient comorbidities on the use and discontinuation of coxibs. Arthritis Rheum. 2003 Jun 15; 49(3):293-9.
Score: 0.014